Member Teleconference
Evidence Based Medicine and Comparative Effectiveness Research
Date: August 13, 2009
Time: 2:00 PM Eastern
The American Recovery and Reinvestment Act of 2009 (Stimulus Bill) included $1.1 billion to fund comparative effectiveness research (CER), which is designed to evaluate the relative economic and clinical value of medical treatments by disease state with the goal of making the healthcare system more efficient. This has the potential to radically change U.S. marketplace dynamics for all segments involved in healthcare delivery. The evidence base it provides will be used to improve the quality of outcomes and also has the potential to impact services and related government payments.
How will it impact you? What is evidence-based medicine (EBM) and how is it related? How is the private sector already engaged in identifying the evidence to create EBM?
Join us for an informative discussion on EBM and CER moderated by Julie Eckstein who leads the CHT Missouri Project. Additionally, we will be joined by special guest speakers:
-
Jean Slutsky, directs the Center for Outcomes and Evidence within AHRQ. Jean leads AHRQ's comparitive effectiveness work and has been a leader within HHS on the subject.
-
Dr. Brian Alper, is the Medical Director of EBSCO Publishing and Editor in Chief & Founder of DYNAMED. Dr. Alper will be presenting on the role of EBM in improving quality and lowering overall costs.
